[Evaluation of intratumoral injection of an immunopotentiator (OK-432) in patients with hepatocellular carcinoma].
D001688:Biological Products / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D006801:Humans; D007267:Injections; D008113:Liver Neoplasms / Q000628:therapy*; D010844:Picibanil / Q000008:administration & dosage*
D001688:Biological Products; D010844:Picibanil